Do I need an in-person exam for Ozempic in Florida?

If you’ve been wondering whether you can legally access medications like Wegovy, Ozempic, or Mounjaro through telehealth, you’re not alone. With the rise of virtual healthcare and the growing demand for effective weight loss treatments, understanding the rules around telehealth prescribing has never been more important.

The short answer is yes—in most cases, you can legally obtain GLP-1 weight loss medications through telehealth across the United States. But the specific requirements vary by state, and navigating these regulations can feel overwhelming. This guide breaks down everything you need to know about telehealth prescribing for weight loss medications, including state-specific rules, provider qualifications, and what to expect from your virtual visit.

Understanding Federal Rules: The Foundation of Telehealth Prescribing

At the federal level, the good news is straightforward: GLP-1 medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. This means they’re not subject to the Ryan Haight Act’s in-person examination requirement that applies to medications like Adderall or opioids.

While federal telehealth flexibilities for controlled substances have been extended through December 31, 2025, these temporary pandemic-era rules don’t actually affect non-controlled medications like GLP-1 agonists. These weight loss medications have always been prescribable via telehealth under federal law, as long as a valid patient-provider relationship is established.

What does ‘valid patient-provider relationship’ mean? Generally, this requires:

• A live video consultation (not just a questionnaire)
• A thorough medical history review
• Documentation of your current health status
• An appropriate treatment plan with follow-up care

The provider must also be licensed in the state where you’re physically located at the time of the consultation—this is a critical requirement that legitimate telehealth platforms like Klarity Health strictly follow.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Variations: What You Need to Know

While federal law sets the baseline, individual states have the authority to impose additional requirements for prescribing weight loss medications via telehealth. These variations typically fall into a few categories:

In-Person Examination Requirements

Some states require an initial in-person physical examination before or shortly after starting telehealth treatment for weight loss. States with this requirement include:

Arkansas has among the strictest telehealth regulations in the country, requiring an initial in-person exam to establish the patient-provider relationship before prescribing weight loss medications remotely.

Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, and Texas similarly require an initial physical examination, though the specific timing and requirements vary. For example, New Jersey mandates comprehensive lab work and a detailed evaluation including psychological screening before prescribing any weight-loss medication.

Virginia requires not only an initial physical exam and lab tests but also a documented diet and exercise plan, with mandatory follow-up within 30 days of starting therapy.

States Allowing Full Telehealth Access

Many states have no in-person requirement for weight loss medication prescribing via telehealth, including:

California, Connecticut, Illinois, New York, Pennsylvania, Utah, and Washington allow providers to conduct the entire evaluation and ongoing care virtually, as long as the standard of care is maintained.

These states recognize that telehealth can provide appropriate medical care for obesity treatment without requiring patients to travel for in-person visits—removing a significant barrier to accessing care.

Special State Requirements

Beyond in-person exam rules, some states have additional requirements:

Florida mandates that patients have a BMI of 30 or higher and requires follow-up visits at least every three months during treatment. Patients must also be counseled on lifestyle modifications.

Connecticut requires that obesity treatment include behavioral counseling and a documented diet and exercise plan alongside medication.

Washington has strong health data privacy protections under the My Health My Data Act, which requires telehealth providers to implement specific safeguards for sensitive weight-loss information.

Who Can Prescribe Weight Loss Medications via Telehealth?

The qualifications of your telehealth provider matter—both for legal compliance and quality of care. Here’s what you need to know about different types of prescribers:

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathic medicine can prescribe GLP-1 weight loss medications via telehealth in all 50 states, provided they hold an active license in the state where the patient is located. This is the most straightforward scenario with the fewest restrictions.

Nurse Practitioners (NPs)

Nurse Practitioner prescribing authority varies significantly by state:

Independent Practice States (34 states plus DC as of 2025): NPs can evaluate patients and prescribe medications without physician oversight after meeting experience requirements. These states include California, New York, Washington, Arizona, Utah, and Virginia (after two years of practice).

Collaborative Practice States: NPs can prescribe with a physician collaboration agreement or supervisory arrangement. This includes states like Florida, Texas, Pennsylvania, Georgia, and Arkansas.

Recent Expansions: Georgia notably passed legislation in 2024 allowing NPs and PAs to prescribe Schedule II controlled substances with physician delegation—a significant expansion of prescriptive authority, though it doesn’t directly affect GLP-1 medications.

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all states, but most require a supervising physician relationship. The degree of autonomy varies—some states allow PAs significant independence in their prescribing decisions within their collaborative agreement, while others require more direct physician oversight.

Important: When using telehealth services, you may see an NP or PA instead of an MD. This is completely normal and legal. Reputable platforms like Klarity Health ensure all providers are appropriately licensed and credentialed in your state and can legally prescribe the medications they’re offering.

The Telehealth Evaluation Process: What to Expect

Understanding what happens during a telehealth weight loss consultation can help you prepare and ensure you’re working with a legitimate provider.

Initial Consultation

A proper telehealth evaluation for weight loss medication should include:

Comprehensive Medical History: Expect detailed questions about your weight history, previous weight loss attempts, current medications, medical conditions, and family health history. This isn’t just a formality—it’s essential for safety.

Current Health Assessment: You’ll need to provide current vital information including height, weight (most platforms require you to verify this), and blood pressure if available. Some platforms may ask for recent lab results or require you to get lab work done.

Contraindication Screening: Your provider must screen for conditions that would make GLP-1 medications unsafe, including:

• Personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN2)
• Pregnancy or plans to become pregnant
• History of pancreatitis
• Severe gastrointestinal disorders
• Active gallbladder disease

Eligibility Assessment: Generally, you must have a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions like type 2 diabetes, high blood pressure, or high cholesterol. Simply wanting to lose a few pounds for cosmetic reasons typically won’t qualify you for these medications through legitimate providers.

Lifestyle Discussion: Reputable providers will discuss diet, exercise, and behavioral modifications alongside medication. GLP-1 medications are most effective when combined with lifestyle changes—any provider who skips this conversation isn’t following the standard of care.

Informed Consent

Before prescribing, your provider should discuss:

• How the medication works
• Common side effects (nausea, vomiting, diarrhea, constipation)
• Serious but rare risks (pancreatitis, gallbladder problems, thyroid tumors in animal studies)
• The need for ongoing monitoring
• What to do if side effects occur
• The importance of proper injection technique

Many states explicitly require documented informed consent for weight loss medications, particularly New Jersey and Virginia.

Treatment Plan and Follow-Up

Your provider should establish a clear plan including:

• Starting dose and titration schedule
• Follow-up visit timing (typically within 1 month initially, then every 2-3 months)
• Monitoring requirements (some states mandate specific follow-up intervals)
• Lifestyle modification goals
• When to discontinue medication

Red flag: If a telehealth service doesn’t schedule follow-up appointments or doesn’t explain how they’ll monitor your progress, look elsewhere.

Prescription and Pharmacy: Getting Your Medication

Once prescribed, your GLP-1 medication will be sent electronically to a pharmacy—many states now require e-prescribing for all medications.

Legitimate vs. Questionable Sources

✅ Legitimate: Your prescription is sent to a licensed U.S. pharmacy (retail or mail-order). You receive FDA-approved medication in manufacturer packaging (Novo Nordisk for Wegovy/Ozempic, Eli Lilly for Mounjaro/Zepbound).

⚠️ Be Cautious: As of May 2025, the FDA has banned most compounding of semaglutide due to safety concerns after declaring the shortage over. While limited compounding may still occur in specific circumstances, be very wary of any service offering significantly discounted ‘compounded semaglutide’—it may not be legal or safe.

❌ Avoid: Any service offering to ship medication from overseas, sell you medication without a prescription, or provide medication without proper packaging and labeling. These are major red flags for illegitimate operations.

Cost Considerations

• Insurance: Some insurance plans cover GLP-1 medications for obesity, though coverage varies widely. Klarity Health accepts both insurance and self-pay options, providing transparency about costs upfront.
• Manufacturer Programs: Patient assistance programs and savings cards may be available directly from drug manufacturers.
• Self-Pay: Cash prices for brand-name GLP-1 medications typically range from $900-$1,400 per month without insurance.

Supply Limits

Unlike controlled substances, there’s no federal limit on how much can be prescribed at once. However:

• Initial prescriptions are often for 4 weeks to assess tolerance
• Ongoing prescriptions may be for 1-3 months depending on state rules and insurance
• Some providers prefer monthly refills for closer monitoring, especially early in treatment

State-Specific Comparison: At-a-Glance

How Klarity Health Makes Telehealth Weight Loss Accessible

At Klarity Health, we’ve designed our platform to make accessing weight loss medication through telehealth straightforward while maintaining the highest standards of care:

Licensed Providers in Your State: We connect you only with providers who are fully licensed and credentialed in your state, ensuring compliance with local regulations.

Comprehensive Evaluations: Our providers conduct thorough assessments via live video consultation, not just questionnaires. You’ll discuss your medical history, weight loss goals, and overall health in detail.

Transparent Pricing: Whether you’re using insurance or paying cash, you’ll know the cost upfront. We accept both insurance and self-pay, removing financial uncertainty from the equation.

Convenient Access: With provider availability that fits your schedule, you can often get an appointment within days, not weeks or months—a significant advantage over traditional weight loss clinics where wait times can be extensive.

Ongoing Support: We don’t just write a prescription and disappear. Our platform includes scheduled follow-ups to monitor your progress, adjust dosing, and ensure you’re achieving your health goals safely.

State Compliance: We stay current on all state-specific requirements. If your state requires an initial in-person exam, we’ll guide you through that process. If additional documentation is needed, we’ll make sure everything is properly completed.

Common Questions About Telehealth Weight Loss Medication

Q: Is telehealth weight loss medication as safe as in-person treatment?

A: When conducted properly, yes. The key is ensuring your provider conducts a comprehensive evaluation, screens for contraindications, provides appropriate monitoring, and is available for follow-up. The medication itself is the same whether prescribed in-person or via telehealth.

Q: What if I have side effects?

A: Reputable telehealth platforms like Klarity Health provide ongoing support. You should have a way to contact your provider between appointments if you experience concerning symptoms. Most side effects (like nausea) are manageable with dose adjustments or supportive care, but your provider needs to know what you’re experiencing.

Q: Can I use my regular insurance?

A: Many telehealth platforms, including Klarity Health, accept insurance. Coverage for the medication itself depends on your specific plan—some insurers cover GLP-1 medications for obesity, while others don’t. The telehealth visit itself is typically covered like any other medical appointment.

Q: How long do I need to stay on the medication?

A: GLP-1 medications for weight loss are generally intended for long-term use. Clinical trials show that weight tends to return when the medication is stopped, so most patients remain on treatment as long as it’s effective and well-tolerated. Your provider will help determine the right duration for your individual situation.

Q: What happens if I move to a different state?

A: Your provider must be licensed in the state where you’re physically located. If you move, you’ll need to transfer care to a provider licensed in your new state. Many telehealth platforms operate in multiple states and can facilitate this transition.

Red Flags: Signs of Illegitimate Telehealth Weight Loss Services

Protect yourself by avoiding services that:

1. Guarantee you’ll get a prescription before evaluating you
2. Don’t require a video consultation with a licensed provider
3. Offer compounded or overseas medications as a ‘cheaper alternative’
4. Skip discussion of risks and side effects
5. Don’t schedule follow-up appointments or monitor your progress
6. Aren’t transparent about provider credentials or licensing
7. Promise dramatic results without discussing lifestyle changes
8. Pressure you into starting immediately without time to consider

If something feels off, trust your instincts. Legitimate providers prioritize your safety over making a quick sale.

The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded telehealth access. Here’s what’s on the horizon:

Federal Legislation: The TREATS Act, reintroduced in October 2025, could make certain telehealth prescribing flexibilities permanent, signaling broader Congressional support for telemedicine.

State Expansions: Multiple states are considering legislation to reduce barriers to NP/PA independent practice and streamline telehealth requirements. Mississippi and Pennsylvania both have bills pending that could expand access significantly.

DEA Rules: While current telehealth flexibilities for controlled substances are set to expire December 31, 2025, extensions are expected. This doesn’t directly affect GLP-1 medications but indicates the direction of telehealth policy overall.

Increased Access: The general trajectory is toward making telehealth more accessible while maintaining appropriate safety standards. This is particularly important for obesity treatment, where in-person visit requirements can create significant barriers for patients who need care most.

Taking the Next Step: Starting Your Telehealth Weight Loss Journey

If you’re considering weight loss medication and wondering whether telehealth is right for you, here’s how to move forward:

1. Check Your Eligibility: Calculate your BMI and review whether you meet the general criteria (BMI ≥30 or ≥27 with weight-related health conditions).

2. Review Your State’s Requirements: Use the information in this guide to understand what to expect based on where you live.

3. Choose a Reputable Provider: Look for established telehealth platforms that are transparent about their process, providers, and costs. Klarity Health offers comprehensive weight loss services with licensed providers available in multiple states.

4. Prepare for Your Consultation: Gather your medical history, current medications, recent weight measurements, and any relevant lab results. Think about your weight loss goals and what lifestyle changes you’re willing to commit to.

5. Stay Engaged: Once you start treatment, keep scheduled follow-up appointments, report any side effects promptly, and work with your provider to optimize your results.

Conclusion: Telehealth Opens Doors to Effective Weight Loss Treatment

The ability to access weight loss medications like Wegovy, Ozempic, and Mounjaro through telehealth represents a significant advancement in obesity care. For many people, the convenience, accessibility, and privacy of virtual visits remove barriers that previously prevented them from seeking treatment.

While state regulations vary, the overall message is clear: telehealth prescribing of GLP-1 medications is legal, safe, and increasingly available across the United States. By understanding your state’s requirements, choosing reputable providers, and committing to comprehensive care that includes lifestyle modifications, you can successfully use telehealth to access the weight loss treatment you need.

Whether you’re just beginning to explore options or you’re ready to schedule your first consultation, platforms like Klarity Health are here to make the process straightforward, compliant with all regulations, and focused on your health and safety.

Ready to take the first step? Klarity Health’s licensed providers are available to evaluate your eligibility and create a personalized weight loss plan that works for you—all from the comfort and privacy of your own home.

Research Citations

1. DEA Announcement (Nov 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ www.dea.gov

2. Axios News – COVID-era telehealth prescribing extended www.axios.com

3. McDermott Law – Insight on DEA Telemedicine rules www.mwe.com

4. Goodwin Law Alert – Weight-Loss Drugs regulatory landscape www.goodwinlaw.com

5. Reuters News – Hims & Hers and FDA compounding ban www.reuters.com

Verified as of: December 17, 2025
Note: Telehealth regulations continue to evolve. While this guide reflects current federal and state rules as of December 2025, always verify your state’s most recent requirements with your provider or state medical board.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid